- Home
- ITUB vs GSK Comparison
ITUB vs GSK Comparison
Compare ITUB & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITUB
- GSK
- Stock Information
- Founded
- ITUB 1924
- GSK 1715
- Country
- ITUB Brazil
- GSK United Kingdom
- Employees
- ITUB N/A
- GSK N/A
- Industry
- ITUB Major Banks
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- ITUB Finance
- GSK Health Care
- Exchange
- ITUB Nasdaq
- GSK Nasdaq
- Market Cap
- ITUB 71.1B
- GSK 77.4B
- IPO Year
- ITUB N/A
- GSK N/A
- Fundamental
- Price
- ITUB $6.31
- GSK $38.45
- Analyst Decision
- ITUB Buy
- GSK Hold
- Analyst Count
- ITUB 3
- GSK 2
- Target Price
- ITUB $6.27
- GSK N/A
- AVG Volume (30 Days)
- ITUB 26.5M
- GSK 5.1M
- Earning Date
- ITUB 08-05-2025
- GSK 07-30-2025
- Dividend Yield
- ITUB 6.44%
- GSK 4.13%
- EPS Growth
- ITUB 25.90
- GSK N/A
- EPS
- ITUB 0.67
- GSK 0.98
- Revenue
- ITUB $24,044,475,384.00
- GSK $40,735,668,430.00
- Revenue This Year
- ITUB $36.38
- GSK $6.70
- Revenue Next Year
- ITUB $7.66
- GSK $5.42
- P/E Ratio
- ITUB $9.41
- GSK $18.88
- Revenue Growth
- ITUB 6.06
- GSK 2.57
- 52 Week Low
- ITUB $4.42
- GSK $31.72
- 52 Week High
- ITUB $6.95
- GSK $44.67
- Technical
- Relative Strength Index (RSI)
- ITUB 35.87
- GSK 45.78
- Support Level
- ITUB $6.71
- GSK $37.94
- Resistance Level
- ITUB $6.95
- GSK $40.11
- Average True Range (ATR)
- ITUB 0.13
- GSK 0.56
- MACD
- ITUB -0.05
- GSK -0.01
- Stochastic Oscillator
- ITUB 8.49
- GSK 28.23
About ITUB Itau Unibanco Banco Holding SA (Each repstg 500 Preferred shares)
Itaú Unibanco is the largest privately held bank in Brazil, the result of the 2008 merger between Banco Itaú and Unibanco. In addition to Brazil, the bank has significant operations in Chile, Colombia, Argentina, Uruguay, and Paraguay. Itaú's commercial and consumer loans account for 35% and 43% of the bank's total loans, respectively, while foreign loans account for 22% of its portfolio. The bank also operates the fifth-largest insurer in Brazil and is the second-largest asset manager in the country, giving it broad reach over the Brazilian financial system.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.